8-K

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                    FORM 8-K


                Current Report Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934



  Date of Report (Date of earliest event reported): November 22, 2004  



                    Blonder Tongue Laboratories, Inc.      
           (Exact Name of registrant as specified in its charter)


   Delaware          1-14120                    52-1611421
(State or other    (Commission File Number) (I.R.S. Employer
jurisdiction of                              Identification No.)
incorporation)




                One Jake Brown Road, Old Bridge, New Jersey 08857
               (Address of principal executive offices) (Zip Code)


     Registrant's telephone number, including area code: (732) 679-4000


                         Not Applicable                              
          (Former name or former address, if changed since last report)








Item 2.02. Results of Operations and Financial Condition

On November 22, 2004, Blonder Tongue  Laboratories,  Inc. issued a press release
announcing its unaudited financial results for the third quarter ended September
30, 2004. A copy of the press release is attached to this Report as Exhibit 99.1
and is  incorporated  herein by  reference.  The  information  disclosed in this
report,  including  Exhibit 99.1  hereto,  is being  furnished  and shall not be
deemed  "filed" for  purposes of Section 18 of the  Securities  Exchange  Act of
1934.

Item 9.01. Financial Statements and Exhibits

     (a) Not applicable


     (b) Not applicable


     (c) The following exhibits are filed herewith:


     Exhibit 99.1         Press Release dated November 22, 2004.







                                    SIGNATURE


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                          BLONDER TONGUE LABORATORIES, INC.



                          By:  /s/Eric Skolnik
                               Eric Skolnik
                               Senior Vice President and Chief Financial Officer

Date: November 22, 2004





                                  EXHIBIT INDEX


Exhibit No.           Description

Exhibit 99.1          Press Release of Blonder Tongue Laboratories, Inc. dated
                      November 22, 2004 regarding  unaudited  financial results
                      for the third quarter ended September 30, 2004

EX-99

[BLONDER TONGUE LABORATORIES, INC.LOGO]


                                                           One Jake Brown Road
                                                     Old Bridge, NJ 08857-1000
                                             (732) 679-4000 Fax (732) 679-4353
                                                         www.blondertongue.com


For Immediate Release:                 Contact:         James A. Luksch
November 22, 2004                                       Chairman and
                                                        Chief Executive Officer
                                                        (732) 679-4000


              BLONDER TONGUE REPORTS THIRD QUARTER 2004 RESULTS


OLD BRIDGE, NEW JERSEY,  November 22, 2004 - Blonder Tongue  Laboratories,  Inc.
(AMEX:  "BDR") today  reported net sales of  $11,215,000  for the third  quarter
2004, a 22 % increase over net sales of $9,195,000 reported in the third quarter
2003.

Earnings for the third quarter 2004 were $406,000, or $0.05 per share, a marked
improvement over last year's net loss of $65,000, or ($0.01) per share, for the
comparable period.

Commenting on the third quarter 2004 results, James A. Luksch, Chief Executive
Officer, said, "Third quarter results show a significant improvement over the
third quarter for 2003 and our expectations are for continued long-term growth
in revenues and profits.  40% of the  quarter to quarter top line growth was
achieved with increased sales from the Company's data and telephony product
lines.  These products combined with our core analog and digital television
products, as well as the QT series of QAM Transcoders,  including the QTM-HD
transcoder module for high definition programming, complete the Blonder Tongue
Triple  Play  needed by our customers to compete in today's marketplace.  The
Company's introduction  of its TV Channel Blocker, which allows consumers to
restrict access to undesirable  programming, should begin to contribute to
further increase in sales in 2005 and continue in the years  ahead.  The market
potential for increased sales of these products is much greater than that which
has been realized to date."

Founded  in 1950, Blonder Tongue Laboratories is a leading U.S. designer,
manufacturer, and supplier of a comprehensive line of broadband systems
equipment and technical engineering services for Voice, Video and Data service
providers.  With optimized technologies, simplified deployment and qualified
technical assistance, the service provider reduces costs, increases customer
satisfaction and increases profitability. For more information regarding Blonder
Tongue or its products, please visit the Company's Web site at
www.blondertongue.com or contact the Company directly at (732) 679-4000.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of
1995: The information set forth above includes "forward-looking" statements and
accordingly, the cautionary statements contained in Blonder Tongue's Annual
Report and Form 10-K/A for the year ended December 31, 2003  (See Item 1:
Business and Item 7: Management's Discussion and Analysis of Financial Condition
and Results of Operations), and other filings with the Securities and Exchange
Commission are incorporated herein by reference.  The words"believe", "expect",
"anticipate", "project", and similar expressions identify forward-looking
statements.  Readers are cautioned not to place undue reliance on these
forward-looking statements, which reflect management's analysis only as of the
date hereof.  Blonder Tongue undertakes no obligation to publicly revise these
forward-looking statements to reflect events or circumstances that arise after
the date hereof. Blonder Tongue's actual results may differ from the anticipated
results or other  expectations  expressed in Blonder Tongue's "forward-looking"
statements.


                                                     -MORE-



                        Blonder Tongue Laboratories, Inc.
                    Consolidated Summary of Operating Results
                      (in thousands, except per-share data)
                                   (unaudited)


                                        Three months ended   Nine months ended
                                           September 30,    September 30,

              2004      2003        2004       2003


Net sales                                 $11,215    $9,195   $30,661    $26,331
Gross profit                                3,580     2,965     9,601      7,799
Earnings (loss) from operations               660       188       785     (1,116)
Net earnings (loss)                           406       (65)      245     (1,213)
Net earnings (loss) per share:
   Basic                                    $0.05     $(0.01)   $0.03     $(0.16)
   Diluted                                  $0.05     $(0.01)   $0.03     $(0.16)

Weighted average shares outstanding:
   Basic                                    8,002      7,577    7,995      7,539
   Diluted                                  8,026      7,577    8,033      7,539






                       Consolidated Summary Balance Sheets
                                 (in thousands)


                                   September 30, 2004   December 31, 2003
                                              (unaudited)

Current assets                                   $17,357              $18,951
Property, plant, and equipment, net                6,226                6,652
Total assets                                      43,590               47,990
Current liabilities                                8,744                7,360
Long-term liabilities                              3,696                9,745
Stockholders' equity                              31,150               30,885

Total liabilities and stockholders' equity       $43,590              $47,990